Ananda Scientific, Inc.
Liquid Structure™ proprietary drug delivery system for oral bioavailability and absorption of active pharmaceutical ingredients
- Sector
- Biotech
- Headquarters
- GREENWOOD VILLAGE, CO
- Latest Form D
- $2.4M, Jan 2019
- Total capital
- $2.4M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $2.4M
- 1 Form D · last Jan 2019
- 93 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 6 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$2.4M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Ariel B. G. StrahovskyExecutive OfficerNamed in SEC Form D filings
- Christopher B. G. MooreExecutive OfficerNamed in SEC Form D filings
- Garyn B. G. AngelExecutive OfficerNamed in SEC Form D filings
- Mark A. CoffieDirectorNamed in SEC Form D filings
- Mark J. RosenfeldExecutive Officer, DirectorNamed in SEC Form D filings
- Susan B. G. AlpertDirectorNamed in SEC Form D filings
Show all 7 people
- S. Bryan WilsonDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 6- PendingMethods For Improving Cutaneous Permeation Of Cannabinoids And Fatty Acid AmidesUSPTOApplication 18554605
- PendingMethods For The Treatment Of Anxiety DisorderUSPTOApplication 63338777
- PendingMethods For Improving Cutaneous Permeation Of Cannabinoids And Fatty Acid AmidesUSPTOApplication PCTUS2022024276
Show all 6 patent records
- Methods For Improving Cutaneous Permeation Of Cannabinoids And Fatty Acid AmidesJun 19, 2025 · Application 18554605Pending
- Methods For The Treatment Of Anxiety DisorderApplication 63338777Pending
- Methods For Improving Cutaneous Permeation Of Cannabinoids And Fatty Acid AmidesApplication PCTUS2022024276Pending
- Methods For Treatment Of Chronic Pain With CannabinoidsApplication 63217538Pending
- Methods For Treatment Of Opioid Use Disorder With CannabinoidsApplication 63217536Pending
- Methods For The Treatment Of Ptsd And Tbi With CannabinoidsApplication 63194446Pending
Related companies, and why
- Quarry Thera, LLCSimilar federal contract value in Biotech · null in contracts
- Pheiron, Inc.Similar federal contract value in Biotech · null in contracts
- Aclipse Therapeutics LLCSimilar federal contract value in Biotech · null in contracts
- MS Biotech, Inc.Similar federal contract value in Biotech · null in contracts
- AirNexis TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Starget Pharma Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .